Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02143141 · ClinicalTrials.gov registry record · Phase 4
Low Pain Prediction in Cesarean Section Patients
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT02143141 is a Phase 4 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 13 participants.
The verdict
NCT02143141, a Phase 4 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The investigators are attempting to see if eliminating the amount of long acting spinal narcotic during cesarean section delivery will demonstrate pain scores with movement when evaluated 24 hours postoperatively as those that receive the standard dosage of spinal narcotic when combined with oral acetaminophen or placebo. The investigators also are evaluating if there are decreased side effects related to decreased narcotic usage.
Interventions
- DRUG placebo
- DRUG duramorph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02143141
The ClinicalTrials.gov registry entry for NCT02143141 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02143141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02143141 about?
NCT02143141 is a clinical study titled "Low Pain Prediction in Cesarean Section Patients". The investigators are attempting to see if eliminating the amount of long acting spinal narcotic during cesarean section delivery will demonstrate pain scores with movement when evaluated 24 hours postoperatively as those that receive the standard dosage of spinal narcotic when combined with oral ac...
What is the current status of trial NCT02143141?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2011-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02143141?
The interventions under investigation include: placebo (DRUG), duramorph (DRUG).
Who is sponsoring clinical trial NCT02143141?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.